ArticleBMJ open2026
Effect of ultrasound-guided anterior sacral plexus block on catheter-related bladder discomfort after transurethral prostate surgery: protocol for a single-centre, randomised, double-blind, placebo-controlled trial at a tertiary hospital in China.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCatheter-related bladder discomfort (CRBD) is a common and distressing complication after transurethral prostate surgery (TUPS). Many patients experience moderate to severe symptoms, which may delay recovery and reduce patient satisfaction. Currently, there are no standardised expert consensus statements or international guidelines for CRBD management. The ultrasound-guided anterior approach of sacral plexus block (anterior SPB) is a novel regional anaesthesia technique that may reduce CRBD through effects on multiple neural pathways. This trial is designed to evaluate the efficacy and safety of this technique in patients undergoing TUPS. METHODS AND ANALYSIS: This randomised, double-blind, placebo-controlled trial will enrol 90 male patients aged 50-80 years who are scheduled for elective TUPS under general anaesthesia. Participants will be randomly assigned (1:1) to receive either bilateral anterior SPB with 0.25% ropivacaine (20 mL per side) or saline placebo after anaesthesia induction. The primary outcome is the incidence of moderate-to-severe CRBD within 24 hours postoperatively. Secondary outcomes include the overall incidence and severity of CRBD, postoperative pain scores, rescue analgesia requirement, opioid consumption, emergence agitation, time to ambulation, quality of recovery, patient satisfaction and length of hospital stay. Safety outcomes include block-related, surgery-related and systemic adverse events. Data will be analysed using both modified intention-to-treat and per-protocol approaches. ETHICS AND DISSEMINATION: Ethical approval was obtained from the Ethics Committee of Beijing Chaoyang Hospital Affiliated to Capital Medical University on 25 April 2025 (2025-Ke-405-1). The results will be disseminated through peer-reviewed publications and presentations at academic conferences. TRIAL REGISTRATION NUMBER: ChiCTR2500102595.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.